Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy

J Am Coll Cardiol. 2004 Feb 18;43(4):670-7. doi: 10.1016/j.jacc.2003.09.046.

Abstract

Objectives: The present study introduces a modification of the diastolic coronary conductance concept that maintains its sensitive properties to detect changes in the coronary microcirculation in human hypertrophy.

Background: Decrements of coronary flow in hypertrophy have been explained by changes in the coronary microcirculation. No measure is available to detect these changes.

Methods: Doppler velocity catheters were introduced into the left anterior descending artery (LAD) and left circumflex coronary artery (LCx) of patients with obstructive hypertrophic cardiomyopathy (HCM) (n = 11) and into the LAD of cardiac transplant recipients (n = 9). The diastolic coronary conductance was measured at rest and after maximal hyperemia induced by a bolus injection of adenosine. Diastolic coronary vasodilator reserve (DCVR) was calculated as the hyperemic diastolic coronary conductance, divided by the coronary conductance during resting conditions.

Results: Left ventricular outflow tract gradient in the HCM group (83 +/- 31 mm Hg) was significantly higher (p < 0.05). Septal wall thickness was significantly increased (p < 0.05), while wall thickness was unchanged in the posterior wall of the HCM group. The coronary flow reserve was significantly decreased in the HCM-LCx region (to 64 +/- 7% of control) and in the HCM-LAD regions (to 57 +/- 7% of control). The DCVR was only decreased in the HCM-LAD (to 46 +/- 3% of control) and not in the HCM-LCx group (86 +/- 6%, p > 0.05). Esmolol did affect the pressure gradient and systolic shortening, but did not affect the maximal diastolic conductance.

Conclusions: The DCVR, in contrast with the coronary flow reserve, is decreased in those regions that display a disturbance in the microcirculation and may, therefore, offer a new way to study coronary adaptations in patients with hypertrophy.

MeSH terms

  • Adenosine
  • Adrenergic beta-Antagonists
  • Blood Flow Velocity / physiology
  • Cardiac Catheterization
  • Cardiac Pacing, Artificial
  • Cardiomyopathy, Hypertrophic / diagnostic imaging
  • Cardiomyopathy, Hypertrophic / physiopathology*
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Circulation / physiology*
  • Diastole / physiology
  • Echocardiography
  • Heart Transplantation / physiology
  • Humans
  • Microcirculation / physiology
  • Middle Aged
  • Propanolamines
  • Ultrasonography, Interventional
  • Vasodilator Agents

Substances

  • Adrenergic beta-Antagonists
  • Propanolamines
  • Vasodilator Agents
  • Adenosine
  • esmolol